Literature DB >> 26608316

Mutated but Not Deleted Ovine PrP(C) N-Terminal Polybasic Region Strongly Interferes with Prion Propagation in Transgenic Mice.

Manal Khalifé1, Fabienne Reine2, Sophie Paquet-Fifield2, Johan Castille1, Laetitia Herzog2, Marthe Vilotte1, Mohammed Moudjou2, Katayoun Moazami-Goudarzi1, Samira Makhzami1, Bruno Passet1, Olivier Andréoletti3, Didier Vilette4, Hubert Laude2, Vincent Béringue5, Jean-Luc Vilotte6.   

Abstract

UNLABELLED: Mammalian prions are proteinaceous infectious agents composed of misfolded assemblies of the host-encoded, cellular prion protein (PrP). Physiologically, the N-terminal polybasic region of residues 23 to 31 of PrP has been shown to be involved in its endocytic trafficking and interactions with glycosaminoglycans or putative ectodomains of membrane-associated proteins. Several recent reports also describe this PrP region as important for the toxicity of mutant prion proteins and the efficiency of prion propagation, both in vitro and in vivo. The question remains as to whether the latter observations made with mouse PrP and mouse prions would be relevant to other PrP species/prion strain combinations given the dramatic impact on prion susceptibility of minimal amino acid substitutions and structural variations in PrP. Here, we report that transgenic mouse lines expressing ovine PrP with a deletion of residues 23 to 26 (KKRP) or mutated in this N-terminal region (KQHPH instead of KKRPK) exhibited a variable, strain-dependent susceptibility to prion infection with regard to the proportion of affected mice and disease tempo relative to findings in their wild-type counterparts. Deletion has no major effect on 127S scrapie prion pathogenesis, whereas mutation increased by almost 3-fold the survival time of the mice. Deletion marginally affected the incubation time of scrapie LA19K and ovine bovine spongiform encephalopathy (BSE) prions, whereas mutation caused apparent resistance to disease. IMPORTANCE: Recent reports suggested that the N-terminal polybasic region of the prion protein could be a therapeutic target to prevent prion propagation or toxic signaling associated with more common neurodegenerative diseases such as Alzheimer's disease. Mutating or deleting this region in ovine PrP completes the data previously obtained with the mouse protein by identifying the key amino acid residues involved.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26608316      PMCID: PMC4719590          DOI: 10.1128/JVI.02805-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Toward molecular dissection of PrPC-PrPSc interactions.

Authors:  Laura Solforosi; Anne Bellon; Monica Schaller; Justin T Cruite; Gil C Abalos; R Anthony Williamson
Journal:  J Biol Chem       Date:  2007-01-10       Impact factor: 5.157

Review 2.  A general model of prion strains and their pathogenicity.

Authors:  John Collinge; Anthony R Clarke
Journal:  Science       Date:  2007-11-09       Impact factor: 47.728

3.  The sequential development of the brain lesion of scrapie in three strains of mice.

Authors:  H Fraser; A G Dickinson
Journal:  J Comp Pathol       Date:  1968-07       Impact factor: 1.311

4.  Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependent.

Authors:  Michel Dron; Mohammed Moudjou; Jérôme Chapuis; Muhammad Khalid Farooq Salamat; Julie Bernard; Sabrina Cronier; Christelle Langevin; Hubert Laude
Journal:  J Biol Chem       Date:  2010-02-12       Impact factor: 5.157

5.  Identifying key components of the PrPC-PrPSc replicative interface.

Authors:  Gil C Abalos; Justin T Cruite; Anne Bellon; Saskia Hemmers; Junya Akagi; James A Mastrianni; R Anthony Williamson; Laura Solforosi
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

6.  The physical relationship between infectivity and prion protein aggregates is strain-dependent.

Authors:  Philippe Tixador; Laëtitia Herzog; Fabienne Reine; Emilie Jaumain; Jérôme Chapuis; Annick Le Dur; Hubert Laude; Vincent Béringue
Journal:  PLoS Pathog       Date:  2010-04-15       Impact factor: 6.823

7.  Prion protein region 23-32 interacts with tubulin and inhibits microtubule assembly.

Authors:  Katarzyna M Osiecka; Hanna Nieznanska; Krzysztof J Skowronek; Justyna Karolczak; Gabriela Schneider; Krzysztof Nieznanski
Journal:  Proteins       Date:  2009-11-01

8.  Spatial and temporal down-regulation of transgene expression using the TRSID-silencer in mice: application to Prnp.

Authors:  Micaela Gallozzi; Vincent Béringue; Pauline Decaunes; Annick Le Dur; Karine Le Roux; Gaëlle Tilly; Sandrine Le Guillou; Laetitia Herzog; Coralie Peyre; Aline Ladroue; Jérôme Chapuis; Marthe Vilotte; Bruno Passet; José Costa; Nathalie Chenais; Fabienne Le Provost; Hubert Laude; Jean-Luc Vilotte
Journal:  FEBS Lett       Date:  2008-05-22       Impact factor: 4.124

Review 9.  Prion agent diversity and species barrier.

Authors:  Vincent Béringue; Jean-Luc Vilotte; Hubert Laude
Journal:  Vet Res       Date:  2008-06-03       Impact factor: 3.683

10.  Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein.

Authors:  Edward T Parkin; Nicole T Watt; Ishrut Hussain; Elizabeth A Eckman; Christopher B Eckman; Jean C Manson; Herbert N Baybutt; Anthony J Turner; Nigel M Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-15       Impact factor: 11.205

View more
  3 in total

1.  Mutant-selective topologic conversion facilitates selective degradation of a pathogenic prion isoform.

Authors:  Yumi Lee; Hongsik Eum; Duri Lee; Sohee Lee; Youngsup Song; Sang-Wook Kang
Journal:  Cell Death Differ       Date:  2019-05-24       Impact factor: 15.828

2.  Glycoform-independent prion conversion by highly efficient, cell-based, protein misfolding cyclic amplification.

Authors:  Mohammed Moudjou; Jérôme Chapuis; Mériem Mekrouti; Fabienne Reine; Laetitia Herzog; Pierre Sibille; Hubert Laude; Didier Vilette; Olivier Andréoletti; Human Rezaei; Michel Dron; Vincent Béringue
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

Review 3.  N-Terminal Regions of Prion Protein: Functions and Roles in Prion Diseases.

Authors:  Hideyuki Hara; Suehiro Sakaguchi
Journal:  Int J Mol Sci       Date:  2020-08-28       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.